Article Details

Alchemab Therapeutics Appoints Douglas A. Treco, PhD as Chief Executive Officer

Retrieved on: 2021-06-22 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Alchemab Therapeutics Appoints Douglas A. Treco, PhD as Chief Executive Officer. View article details on hiswai:

Excerpt

From January 2008 to May 2014, Dr. Treco served as an entrepreneur-in-residence with Morgenthaler Ventures and was a visiting scientist in the ...

Article found on: www.joplinglobe.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up